share_log

华纳药厂(688799.SH):硫酸特布他林雾化吸入用溶液获得药品补充申请批准通知书

Warner Pharmaceuticals (688799.SH): The pharmaceutical supplementary application approval notice for the aerosol inhalation solution of terbutaline sulfate has been obtained.

Gelonghui Finance ·  Oct 17 04:36

On October 17, Gelonghui announced that Warner Pharmaceutical Factory (688799.SH) received the "Drug Supplementary Application Approval Notice" issued by the National Medical Products Administration regarding the change of the pharmaceutical license holder for the market approval of the pharmaceutical solution of terbutaline sulfate for inhalation. Terbutaline sulfate inhalation solution is suitable for relieving bronchial asthma, chronic bronchitis, emphysema, and bronchospasm associated with other pulmonary diseases.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment